The number of monthly unique payers increased about 13 percent to 2.9 million in the fourth quarter from the prior quarter.
Second, efforts to control rising health care costs have provided hospitals, managed care organizations and payers increasing incentives to allocate expenditures more efficiently for patients likely to be close to the end of life.
A recent study explored the prevalence of SI joint fusion and the frequency with which it is being performed using a MIS technique in the US. 31 The total number of estimated SI joint fusion procedures (all payers) increased from 189 in 2001 to 3,900 in 2012.
In summary, Holahan grossly underestimates the administrative savings under single payer; projects increases in the number of doctor visits and hospitalizations that far exceed the capacity of doctors and hospitals to provide this added care; and posits that our country would continue to pay much more for drugs and medical equipment than people in every other nation with national health insurance.
Cumulative costs, that is, commercial payer reimbursement, increased over the 3-year period for the overall group and subgroups.
However, this study suggests that, from a UK payer perspective, increasing the proportion of patients on PD could lead to cost reductions while also improving clinical outcomes and QoL, thus alleviating the burden to the patient.
Our results demonstrate that considerable savings in the transportation costs related to dialysis services could be made by the payer by increasing the uptake of home-based dialysis regimens.
So CloudMedx's sales strategy pushes network effects at a more realistic scale — bringing in physician organizations means you deal with fewer payers and increase the likelihood that the patients involved will move between doctors at the same organization, increasing utilization.
Ken Livingstone, the mayor of London, has pledged an extra £300m, without further rises for the capital's council tax payers or increased transport fares.
Importantly, the ability to identify those patients who will have higher treatment response rates and will experience fewer adverse events and/or side effects will serve as a powerful driver of value as payers balance increasing healthcare costs against healthcare funding constraints and shrinking budgets.
For years, they did so by denying coverage to those with pre-existing conditions and by otherwise cherry picking premium payers to increase the chances that those payers would never actually need health care.
